Advertisement
Screener

ImmuCell Corporation (ICCC) Accounts Receivable, Sale

2.0 / 5 stars · 44/111 Roast Me

ImmuCell Corporation Accounts Receivable, Sale

ImmuCell Corporation (ICCC) reported Accounts Receivable, Sale of $6.10 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-10.

Discontinued › Notes › Credit Losses

us-gaap:AccountsReceivableSale · last filed 2023-08-10

  • ImmuCell Corporation accounts receivable, sale for the quarter ending 2023-06-30 was -$551.00.
  • ImmuCell Corporation accounts receivable, sale for the quarter ending 2023-03-31 was $6.65K.
  • ImmuCell Corporation accounts receivable, sale for fiscal 2021 was $55.49K.
Period endAccounts Receivable, Sale 3 monthAccounts Receivable, Sale 6 monthAccounts Receivable, Sale 12 month
2023-06-30-$551.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10
$6.10K
10-Q · filed 2023-08-10
2023-03-31$6.65K
10-Q · filed 2023-05-11
2022-12-31$46.43K
10-Q · filed 2023-08-10
2021-12-31$55.49K
10-K · filed 2023-03-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92